Acesso livre
Acesso livre

Vacinas

Gestantes não vacinadas estão sob maior risco de complicações decorrentes da Covid e de morte do bebê.

17 Jan, 2022 | 13:19h

Unvaccinated pregnant people are at higher risk for Covid complications and newborn deaths – STAT

Estudo original: SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland – Nature Medicine


Dados mostram que as vacinas contra COVID protegem as gestantes.

17 Jan, 2022 | 13:17h

COVID vaccines safely protect pregnant people: the data are in – Nature

Conteúdos relacionados:

COVID-19 vaccination in pregnancy—number needed to vaccinate to avoid harm.

A case-controlled study showed Covid-19 vaccination during early pregnancy was not associated with increased risk of first-trimester miscarriage.

Editorial: Covid-19 treatments and vaccines must be evaluated in pregnancy.

AstraZeneca vaccination not linked to reduced fertility rates and adverse birth outcomes.

Cohort study: Vaccinated pregnant patients had 90% lower risk of severe or critical Covid-19 compared with unvaccinated pregnant patients.

Two observational studies suggest spontaneous abortion is not increased following COVID-19 mRNA vaccination during pregnancy.

Study shows high effectiveness of the Pfizer mRNA COVID-19 vaccine in pregnancy.

5 Crucial Things to Know About COVID-19 Vaccines and Pregnancy.

CDC Guidance: Pregnant people should be vaccinated against COVID-19.

ACOG and SMFM Recommend COVID-19 Vaccination for Pregnant Individuals – “ACOG encourages its members to enthusiastically recommend vaccination to their patients.”

Cohort study: Pfizer/BioNTech COVID vaccine associated with 78% lower risk of Covid-19 in pregnancy.


Mapeamento do mundo não vacinado – “Se a terra refletisse o número de pessoas não vacinadas, é assim que o mundo seria.”

17 Jan, 2022 | 13:08h

Mapping the unvaccinated world – Pandemic


Estudo mostra que as vacinas contra COVID-19 oferecem proteção duradoura contra internações e morte.

13 Jan, 2022 | 21:23h

Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines – New England Journal of Medicine

Comunicado de imprensa: Study shows COVID-19 vaccines offer lasting protection – University of North Carolina at Chapel Hill


Estudo observacional em adolescentes mostrou que a vacina da Pfizer-BioNTech teve uma efetividade geral de 94% contra internações e de 98% contra Covid-19 grave.

13 Jan, 2022 | 21:22h

Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents – New England Journal of Medicine

Editorial: Sparing of Severe Covid-19 in Vaccinated Adolescents – New England Journal of Medicine


Um estudo observacional na África do Sul estima que a vacina da Pfizer tenha uma efetividade de 70% contra internação por Covid-19 causada pela variante Ômicron.

13 Jan, 2022 | 21:20h

Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa – New England Journal of Medicine

Comentário: BNT162b2 still effective, but less so, against Omicron – HealthDay


Estudo randomizado | Dose única de uma nova vacina vetorizada de adenovírus tipo 5 contra o SARS-CoV-2 mostrou-se segura e teve eficácia de 57,5% contra Covid-19 sintomática e de 91,7% contra doença grave em adultos.

13 Jan, 2022 | 21:09h

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial – The Lancet

Comentários:

Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine – The Lancet

Phase 3 trial reports one dose of Ad5-nCoV COVID-19 vaccine is safe and effective, including against severe disease – The Lancet


Como as taxas de morte por COVID-19 diferem entre pessoas vacinadas e não vacinadas?

13 Jan, 2022 | 12:04h

How do death rates from COVID-19 differ between people who are vaccinated and those who are not? – Our World in Data

 

Comentário do autor no Twitter

 


Estudo de coorte | Entre profissionais da saúde previamente vacinados com 2 doses da vacina da Pfizer-BioNTech, a aplicação da 3ª dose foi associada com risco reduzido de infecção pelo SARS-CoV-2.

12 Jan, 2022 | 13:11h

Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel – JAMA

Editorial: Booster Vaccination to Reduce SARS-CoV-2 Transmission and Infection – JAMA


Relatório CDC | Segurança da vacina contra COVID-19 em crianças de 5 a 11 anos de idade.

10 Jan, 2022 | 12:49h

COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021 – CDC Morbidity and Mortality Weekly Report

Comentário: COVID-19 vaccine appears safe in children aged 5–11 Years – News Medical

 

Comentário no Twitter

 


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.